# A Pharmacokinetic Study Comparing SCT400 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma

> **NCT02456207** · PHASE2 · UNKNOWN · sponsor: **Sinocelltech Ltd.** · enrollment: 80 (estimated)

## Conditions studied

- B-cell Non Hodgkin's Lymphoma

## Interventions

- **DRUG:** SCT400
- **DRUG:** Rituximab

## Key facts

- **NCT ID:** NCT02456207
- **Lead sponsor:** Sinocelltech Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-05
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2015-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02456207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02456207, "A Pharmacokinetic Study Comparing SCT400 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02456207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*